Claims
- 1. A compound of formula I: whereinX is NR1; R is hydrogen, cycloalkyl, cycloalkenyl, heterocyclyl, heterocyclenyl, fused arylcycloalkyl, fused heteroarylcycloalkyl, fused arylcycloalkenyl, fused heteroarylcycloalkenyl, fused arylheterocyclyl, fused heteroarylheterocyclyl, fused arylheterocyclenyl, fused heteroarylheterocyclenyl, aryl, fused cycloalkenylaryl, fused cycloalkylaryl, fused hieterocyclylaryl, fused heterocyclenylaryl, heteroaryl, fused cycloalkylheteroaryl, fused cycloalkenylheteroaryl, fused heterocyclenylheteroaryl or fused heterocyclylheteroaryl, provided that where L2 is a chemical bond then Q is attached to R through a carbon atom thereof or where R is hydrogen then L2 is not a chemical bond; R1 is hydrogen, alkyl, aralkyl, heteroaralkyl, acyl, aroyl, heteroaroyl, alkoxycarbonyl, aryloxycarbonyl or heteroaryloxycarbonyl; R2 and R3 are hydrogen, or taken together are ═NR4; R4 is hydrogen, R5O2C—, R5O—, HO—, cyano, R5CO—, HCO—, lower alkyl, nitro, or R6R7N—; R5 is alkyl, aryl, heteroaryl, aralkyl, or heteroaralkyl; R6 and R7are independently hydrogen or alkyl; L1 is alkylene, alkenylene or alkynylene; L2 is a chemical bond, alkylene, alkenylene or alkynylene; Q is —NR8′—, —O—, —C(O)—, —C(O)—O—, —O—C(O)—, —NR8′C(X1)—, —C(X1)NR8′—, —NR8C(X1)O—, —OC(X1)NR8—,—NR8C(X1)NR8—, —NR8C(X1)NR8—, —S(O)n—, —NR8SO2— or —SO2NR8—, provided that a nitrogen atom or oxygen atom of Q is not directly bonded to a carbon atom of L1 or L2 having a double bond or triple bond, or Q-L2—R is cycloalkyl, cycloalkenyl, heterocyclyl, heterocyclenyl, fused arylcycloalkyl, fused heteroarylcycloalkyl, fused arylcycloalkenyl, fused heteroarylcycloalkenyl, fused arylheterocyclyl, fused heteroarylheterocyclyl, fused arylheterocyclenyl, fused heteroarylheterocyclenyl, aryl, fused cycloalkenylaryl, fused cycloalkylaryl, fused heterocyclylaryl, fused heterocyclenylaryl, heteroaryl, fused cycloalkylheteroaryl, fused cycloalkenylheteroaryl, fused heterocyclenylheteroaryl or fused heterocyclylheteroaryl, provided that a nitrogen atom or oxygen atom of Q is not directly bonded to a carbon atom of L1 having a double bond or triple bond; X1 is O or S; R8′ is hydrogen, alkyl, aralkyl, heteroaralkyl, acyl, aroyl, heteroaroyl or alkoxycarbonyl; R8 is hydrogen, alkyl, aralkyl, heteroaralkyl, acyl, aroyl or heteroaroyl; and n is 0, 1 or 2, or an oxide thereof, a pharmaceutically acceptable salt thereof, a solvate thereof, or prodrug thereof.
- 2. The compound of claim 1 wherein R is aryl, heteroaryl or heterocyclyl.
- 3. The compound of claim 1 wherein R is substituted phenyl.
- 4. The compound of claim 1 wherein R is (phenyl substituted phenyl), (heteroaryl substituted phenyl), (phenyl substituted heteroaryl), (heteroaryl substituted heteroaryl), (phenyl substituted cyclyoalkyl), (heteroaryl substituted cyclyoalkyl), (cyclyoalkyl substituted heteroaryl), (cyclyoalkyl substituted phenyl), (cyclyoalkyl substituted cyclyoalkyl), (phenyl substituted cyclyoalkenyl), (heteroaryl substituted cyclyoalkenyl), (cyclyoalkenyl substituted heteroaryl), (cyclyoalkenyl substituted phenyl), (cyclyoalkenyl substituted cyclyoalkeny), (phenyl substituted heterocyclyl), (heteroaryl substituted heterocyclyl), (cyclyoalkyl substituted heterocyclyl), (heterocyclyl substituted phenyl), (heterocyclyl substituted heterocyclyl), (phenyl substituted heterocyclenyl), (heteroaryl substituted heterocyclenyl), (cyclyoalkenyl substituted heterocycleryl), (heterocyclenyl substituted phenyl), or (heterocyclenyl substituted heterocyclenyl).
- 5. The compound of claim 1 wherein R is (phenyl substituted phenyl), (heteroaryl substituted phenyl), (phenyl substituted heteroaryl), (heteroaryl substituted heteroaryl), (phenyl substituted heterocyclyl), (heteroaryl substituted heterocyclyl), (cyclyoalkyl substituted heterocyclyl), (heterocyclyl substituted phenyl), (heterocyclyl substituted heterocyclyl), (phenyl substituted heterocyclenyl), (heteroaryl substituted heterocyclenyl), (cyclyoalkenyl substituted heterocyclenyl), (heterocyclenyl substituted phenyl), or (heterocyclenyl substituted heterocyclenyl).
- 6. The compound of claim 1 wherein R is (phenyl substituted heteroaryl), (phenyl substituted heterocyclyl), or (phenyl substituted heterocyclenyl).
- 7. The compound of claim 1 wherein R is (phenyl substituted heteroaryl), (phenyl substituted heterocyclyl), or (phenyl substituted heterocyclenyl); L2 is bonded to said phenyl in the 1-position of the phenyl moiety and said heterocyclyl, heterocyclenyl, or heteroaryl, is bonded to said phenyl in the 4-position of the phenyl moiety.
- 8. The compound of claim 1 wherein R1 is hydrogen.
- 9. The compound of claim 1 wherein R8 is hydrogen.
- 10. The compound of claim 1 wherein R1 and R2 taken together are ═NR4.
- 11. The compound of claim 1 wherein R4 is hydrogen.
- 12. The compound of claim 1 wherein R5 is alkyl.
- 13. The compound of claim 8 wherein R5 is methyl.
- 14. The compound of claim 13 wherein L2 is a chemical bond.
- 15. The compound of claim 1 wherein R6 and R7 are hydrogen.
- 16. The compound of claim 1 wherein Lis alkylene.
- 17. The compound of claim 1 wherein L1 is ethylene.
- 18. The compound of claim 1 wherein L1 is bonded to the 5-position of the moiety.
- 19. The compound of claim 1 wherein L2 is a chemical bond or alkylene.
- 20. The compound of claim 1 wherein X1 is O.
- 21. The compound of claim 1 wherein Q is —NR8CO—, —CONR8—, —NR1SO2— or —SO2NR8—.
- 22. The compound of claim 1 wherein Q is —NR8CO—.
- 23. The compound of claim 1 wherein R8 and R8′ are hydrogen.
- 24. The compound of claim 1 wherein n is 2.
- 25. The compound of claim 1 wherein L1 is bonded to the 5-position of the moiety; and R is (phenyl substituted pyridinonyl), (phenyl substituted pyrrolopyrimidinyl), (phenyl substituted pyridazinyl), (phenyl substituted pyridazinonyl), (phenyl substituted pyridyl), or (phenyl substituted pyrimidinyl).
- 26. The compound of claim 1 wherein R is (phenyl substituted pyrimidinyl), said pyrimidinyl is substituted with at least one ring system substituent selected from the group consisting of alkoxy, Y1Y2N-alkyl-, Y1Y2N—, azaheterocyclyl, Y1Y2NCO-alkylene-O—, azaheterocyclyl-alkylene-O—, and Y1Y2N-alkylene-O—; whereinY1 and Y2 are independently hydrogen, alkyl, alkoxyalkyl, hydroxyalkyl, cycloalkyl, cycloalkyl-alkyl, Y1Y2N-alkyl, aryl, aralkyl, heteroaralkyl, heterocyclylalkyl, heterocyclenylalkyl, or sulfo-alkyl-; or when Y1 is H—CO—, alkyl-CO—, aryl-CO—, or heterocyclyl-CO—, then Y2 is hydrogen, alkyl, aryl, or aralkyl.
- 27. A compound according to claim 1 which is selected from the group consisting ofN-(2-[3-Carbamimidoyl-5-indolyl]ethyl)-4-pyrid-3-ylbenzamide; N-(2-[3-Carbamimidoyl-5-indolyl]ethyl)-4-(pyrimidin-5-yl)-benzamide); 5-(Pyrid-2-yl)-thiophene-2-carboxylic acid 2-(3-Carbamimidoyl-5-indolyl)ethyl amide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-6-morpholin-4-ylnicotinamide4-(5-2[-{3-Carbamimidoylindol-5-yl}ethylcarbamoyl]pyridin-2-yl)piperazine-1-carboxylic acid ethyl ester; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-6-imidazol-1-ylnicotinamide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-4-imidazol-1-ylbenzamide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-4-(3H-imidazol-4-yl)benzamide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-4-(1,2,4)thiadiazol-5-ylbenzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(1-carbamoyl-1-methyl-ethyl-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(1-[N-(2-methoxyethyl)]-carbamoyl-1-methyl-ethyl-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(t-butyl)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(pyridazin-4-yl)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-2-methyl-4-(6-oxo-1,6-dihydro-pyridin-3-yl)-benzamide 3′,4′-Dimethoxybiphenyl-4-carboxylic acid (2-[3-Carbamimidoylindol-5-yl]ethyl)amide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-4-(6-methoxypyrid-3-yl)benzamide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-4-(1-oxy-pyrid-4-yl)benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(7H-pyrrolo[2,3-d]pyrimidin-6-yl)benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-furo[3,2-c]pyridin-2-yl-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-3-chloro-4-(6-oxo-1,6-dihydro-pyridin-3-yl)-benzamide; N-(2-[3-Carbamimidoyl-1H-indol-5-yl]ethyl)-4-(6-oxo-1,6-dihydro-pyrid-3-yl)benzamide; 4-(3-Amino-1,1-dimethyl-propyl)-N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-2-(4-chloro-phenyl)-acetamide; 5-chloro-thiophene-2-carboxylic acid [2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-amide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-6-(2-hydroxyethylamino)nicotinamide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-6-(1,2,4)-triazol-1-ylnicotinamide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-6-pyrrol-1-ylnicotinamide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-6-pyrazol-1-ylnicotinamide; N-(2-[3-Carbamimidoyl-1-methylindol-5-yl]ethyl)-4-(6-methoxypyrid-3-yl)benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-3-chloro-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-2-(3-chloro-phenyl)-acetamide; 4-(2-Aminomethyl-pyridin-4-yl)-N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-benzamide; 4-{4-[2-(3-Carbamimidoy-1H-indol-5-yl)-ethylcarbamoyl]-phenyl-pyridine-2-carboxylic acid amide; N-[2-(3-Carbamimidoy-1H-indol-5-yl)-ethyl]-4-(2-(N,N-dimethylaminomethyl)-pyridin-4-yl)benzamide); N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(6-oxo-1,6-dihydro-pyridazin-3-yl)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(6-methoxy-pyridazin-3-yl)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[1-(2-dimethylamino-ethyl)-6-oxo-1,6-dihydro-pyridazin-3-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[1-(3-dimethylamino-propyl)-6-oxo-1,6-dihydro-pyridazin-3-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(2-dimethylamino-ethylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-methoxy-pyrimidin-4-yl]-benzamide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-4-(1-[2-dimethylaminoethyl]-6-oxo-1,6-dihydropyridin-3-yl)benzamide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-4-(1-carbamoylmethyl-6-oxo-1,6-dihydropyridin-3-yl)benzamide; 4-(3-Amino-[1,2,4]triazin-6-yl)-N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-benzamide; 4-(3-Amino-[1,2,4]triazin-5-yl)-N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(3-oxo-2,3-dihydro-[1,2,4]triazin-6-yl)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5yl)ethyl]-4-(5-oxo-4,5-dihydro-[1,2,4]oxadiazol-3-yl)-benzamide N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-(6-oxo-piperidin-3-yl)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(morpholin-4yl-ethylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(3-dimethylamino-propylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-([2-dimethylamino-ethyl]-methyl-amino)-pyrimidin-4-yl]-benzamide; 2-[(4-{4-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethylcarbamoyl]-phenyl}-pyrimidin-2-yl)-methyl-amino]-ethanesulfonic acid; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-{2-[methyl-(2 (S),3 (R),4 (R),5 (R),6-pentahydroxy-hexyl)-amino]-pyrimidin-4-yl}-benzamide N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-{2-[methyl-(2 (S),3 (R),4 (S),5 (R),6-pentahydroxy-hexyl)-amino]-pyrimidin-4-yl}-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(2-hydroxy-1-hydroxymethyl-ethylamino)-pyrimidin-4-yl]-benzamide; 2-[(4-{4-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethylcarbamoyl]-phenyl}-pyrimidin-2-yl)-methyl-amino]-ethanesulfonic acid; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(3-imidazol-1-yl-propylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-{2-[(2-diethylamino-ethyl)methyl-amino]-pyrimidin-4-yl}-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(2-diisopropylamino-ethylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(2-dibutylamino-ethylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(3-morpholin-4-yl-propylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(3-diethylamino-propylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(3-piperidin-1-yl-propylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(2-{[2-(ethyl-methyl-amino)-ethyl]-methyl-amino}-pyrimidin-4-yl)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(5-dimethylamino-pentylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(5-morpholin-4-yl-pentylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(5-piperidin-1-yl-pentylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(5-pyrrolidin-1-yl-pentylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(2-oxo-hexahydro-pyrimidin-5-yl)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(1,3-dimethyl-2-oxo-hexahydro-pyrimidin-5-yl) benzamide; Biphenyl-3,4′-dicarboxylic acid 4′-{[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-amide} 3-[(2-methoxy-ethyl)-amide]; 3′-(Morpholine-4-carbonyl)-biphenyl-4-carboxylic acid [2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-amide; Biphenyl-3,4′-dicarboxylic acid 4′-{[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-amide} 3-[(2-morpholin-4-yl-ethyl)-amide]; Biphenyl-2,4′-dicarboxylic acid 4′-{[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-amide} 2-[(3-diethylamino-propyl)-amide]; Biphenyl-2,4′-dicarboxylic acid 4′-{[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-amide} 2-[(3-morpholin-4-yl-propyl)-amide]; Biphenyl-2,4′-dicarboxylic acid 4′-{[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-amide} 2-[(3-piperidin-1-yl-propyl)amide]; Biphenyl-2,4′-dicarboxylic acid 4′-{[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-amide} 2-[(4-dimethylamino-butyl)-amide]; Biphenyl-2,4′-dicarboxylic acid 4′-{[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-amide} 2-[(2,3-dihydroxy-propyl)-methyl-amide]; Biphenyl-2,4′-dicarboxylic acid 4′-{[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-amide} 2-[(2,3-dihydroxy-propyl)-amide]; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(4-methylpiperazin-1-yl)pyrimidin-4-yl]benzamide; 4-[(4-{4-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethylcarbamoyl]phenyl}pyrimidin-2-yl)methylamino]butyric acid; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(2,2,2-trifluoroethoxy)pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(2-pyrrolidin-1-ylpyrimidin-4-yl)benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(2-hydroxymethylpyrrolidin-1-yl)-pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(carbamoylmethyl-N-methylamino)-pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(6-pyrrolidin-1-yl-hexylamino)pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(6-piperidin-1-ylhexylamino)pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(4-piperidin-1-ylbutylamino)pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(4-diethylaminobutylamino)pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(6-morpholin-4-ylhexylamino)pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(6-dimethylaminohexylamino)pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(4-dimethylaminobutylamino)pyrimidin-4-yl]benzamide; 4-[2-(Bicyclo[2;2;1]hept-2-ylamino)pyrimidin-4-yl]-N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]benzamide; 1-(4-{4-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethylcarbamoyl]phenyl}pyrimidin-2-yl)pyrrolidine-2-carboxylic acid amide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-{2-[(2-hydroxy-ethyl)-N-methylamino]pyrimidin-4-yl}benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(2-morpholin-4-yl-pyrimidin-4-yl)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(cyclopropylmethyl-amino)-pyrimidin-4-yl]-benzamide; N-[2-(Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-[(2-methoxy-ethyl)-methyl-amino]-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(3-hydroxy-propylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[(2-hydroxy-ethyl)-propyl-amino]-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indole-5yl)-ethyl]-4-(2-piperidin-1-yl-pyrimidin-4-yl)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(ethyl-methyl-amino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(4-hydroxy-piperidin-1-yl)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(2,3-dihydroxy-propylamino)-pyrimidin-4-y]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-[(2,3-dihydroxy-propyl)-methyl-amino]-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-((s)-2-methoxymethyl-pyrrolidin-1-yl)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(2-piperazin-1-yl-pyrimidin-4-yl)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-4-[2-[2-(2-oxo-imidazolidin-1-yl)-ethylamino]-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(3-methoxy-propylamino)-pyrimidin-4-yl]-benzamide; 4-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(2-hydroxy-ethylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(2-methoxyethoxy)-pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(1-Carbamoylethoxy)pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(6-dimetyainoheyloxy)pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(2-pyrrolidin-1-yl-ethoxy)pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(2-dimethylaminoethoxy)pyrimidin-4-yl]benzamide; 3′-(2-Dimethylaminoethoxy)biphenyl-4-carboxylic acid [2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]amide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-(1-oxypyridin-2-yl)benzamide; 2′-(2-Dimethylaminoethoxy)biphenyl-4-carboxylic acid [2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]amide; 2′-(3-Dimethylaminopropoxy)biphenyl-4-carboxylic acid [2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]amide; 3′-(3-Dimethylaminopropoxy)biphenyl-4-carboxylic acid [2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]amide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(1-oxo-pyridin-3-yl)-benzamide; 4-[2-(acetylamino-methyl)-pyridin-4-yl]-N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-benzamide; Piperidine-4-carboxylic acid (4-[4-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethylcarbamoyl]-phenyl-]-pyridin-2-ylmethyl)-amide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[]-(3-dimethylaminopropyl)-6-oxo-1,6-dihydropyridin-3-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[6-(3-dimethylaminopropoxy)pyridin-3-yl]benzamide; (5-{4-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethylcarbamoyl]phenyl}-2-oxo-2H-pyridin-1-yl)acetamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-{1-[(2-dimethylaminoethylcarbamoyl)methyl]-6-oxo-1,6-dihydropyridin-3-yl}benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(4-dimethylamino-piperidin-1-yl)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-y)-ethyl]-4-[4-(2-dimethylamino-ethylamino)-piperidin-1-yl-]benzamide; 4-(4-Amino-piperidin-1-yl)-N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(4-methoxy-piperidin-1-yl)-benzamide; 4-(4-Acetylamino-piperidin-1-yl)-N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-benzamide; 4-(1-Acetyl-piperidin-4-yl)-N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-benzamide; 4-{4-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethylcarbamoyl]-phenyl}-piperidine-1-carboxylic acid amide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(1-methyl-1-oxy-piperidin-4-yl)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(1-methyl-piperidin-4-yl)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(1-methanesulfonyl-piperidin-4-yl)-benzamide; 4-(2-Acetylamino-1,1-dimethyl-ethyl)-N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(2-methanesulfonylamino-1,1-dimethyl-ethyl)-benzamide; Piperidine-4-carboxylic acid (2-{4-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethylcarbamoyl]-phenyl}-2-methyl-propyl)-amide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(1,1-dimethyl-2-ureido-ethyl)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(3-ethyl-ureido)-1,1-dimethyl-ethyl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(2-dimethylamino-3,4,5,6-tetrahydro-pyrimidin-4-y)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(1-oxy-pyridin-4-yloxy)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(1-methyl-piperidin-4-yloxy)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-(1,2,3,6-tetrahydropyridin-4-yl)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-piperidin-4-yl-benzamide; 4-(2-Amino-1,1-dimethylethyl)-N-(2-[3-Carbamimidoylindol-5-yl]ethyl)benzamide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-4-(6-[2-dimethylaminoethoxy]pyridin-3-yl)benzamide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-4-pyrid-4-ylbenzamide; N-(2-[3-Carbamimidoyl indol-5-yl]ethyl)-4-(4-carbamoyl-phenyl)-benzamide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-4-(4-methoxy-phenyl)-benzamide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-(5-methoxy-indol-2-yl)-carboxamide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-(6-chloro-benzothiophen-2-yl)-carboxamide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-4-(4-benzyloxy-phenyl)-benzamide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-4-chloro-benzamide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-4-(methylsulphonyl)-benzamide; N-(2-[3-Carbamimidoyl indol-5-yl]ethyl)-4-(amino-sulphonyl)-benzamide; 4-(3-Aminoprop-1-ynyl)-N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-benzamide; 5-{4-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethylcarbamoyl]phenyl}-2-oxo-2H-pyridin-1-yl)acetic acid; and 3-Carbamimidoyl-5-{2-[4-(6-oxo-1,6-dihydro-pyridin-3-yl)-benzoylamino]-propyl}-indole.
- 28. A compound according to claim 27 which is selected from the group consisting ofN-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(pyridazin-4-yl)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-2-methyl-4-(6-oxo-1,6-dihydro-pyridin-3-yl)-benzamide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-4-(6-methoxypyrid-3-yl)benzamide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-4-(1-oxy-pyrid-4-yl)benzamide; N-[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(7H-pyrrolo[2,3-d]pyrimidin-6-yl)-benzamide; N-[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)-benzamide; N-[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-3-chloro-4-(6-oxo-1,6-dihydro-pyridin-3-yl)-benzamide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-4-(6-oxo-1,6-dihydropyrid-3-yl)benzamide; 4-(3-Amino-1,1-dimethyl-propyl)-N-[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-benzamide; 4-(2-Aminomethyl-pyridin-4-yl)-N-[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-benzamide; 4-{4-[2-(3-Carbamimidoy-1H-indol-5-yl)-ethylcarbamoyl]-phenyl-pyridine-2-carboylic acid amide; N-[2-(3-Carbamimidoy-1H-indol-5-yl-ethyl]-4-(2-(N,N-dimethylaminomethyl)-pyridin-4-yl)benzamide); N-[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(6-oxo-1,6-dihydro-pyridazin-3-yl)benzamide; N-[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(6-methoxy-pyridazin-3-yl)-benzamide; N-[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[ 1-(2-dimethylamino-ethyl)-6-oxo-1,6-dihydro-pyridazin-3-yl]-benzamide; N-[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[ 1-(3-dimethylamino-propyl)-6-oxo-1,6-dihydro-pyridazin-3-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(2-dimethylamino-ethylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-methoxy-pyrimidin-4-yl]-benzamide; N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-4-(1-[2-dimethylaminoethyl]-6-oxo-1,6-dihydropyridin-3-yl)benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-(6-oxo-piperidin-3-yl)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(morpholin-4yl-ethylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(3-dimethylamino-propylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-([2-dimethylamino-ethyl]-methyl-amino)-pyrimidin-4-yl]-benzamide; 2-[(4-{4-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethylcarbamoyl]-phenyl}-pyrimidin-2-yl)-methyl-amino]-ethanesulfonic acid; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-2-[methyl-(2 (S),3 (R),4 (R),5 (R),6-pentahydroxy-hexyl)-amino]-pyrimidin-4-yl}-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-{2-[methyl-(2 (S),3 (R),4 (S),5 (R),6-pentahydroxy-hexyl)-amino]-pyrimidin-4-yl}-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(2-hydroxy-1-hydroxymethyl-ethylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(3-imidazol-1-yl-propylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-ethyl)-ethyl]-4-{2-[(2-dimethylamino-ethyl)-methyl-amino]-pyrimidin-4-yl}-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(2-diisopropylamino-ethylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(2-dibutylamino-ethylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-y)-ethyl]-4-[2-(3-morpholin-4-y-propylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(3-diethylamino-propylamino)-pyrimidin-4-yl-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(3-piperidin-1-yl-propylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(2-{[2-(ethyl-methyl-amino)-ethyl]-methyl-amino}-pyrimidin-4-yl)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(5-dimethylamino-pentylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(5-morpholin-4-yl-pentylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(5-piperidin-1-yl-pentylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(5-pyrrolidin-1-yl-pentylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(2-oxo-hexahydro-pyrimidin-5-yl)-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(1,3-dimethyl-2-oxo-hexahydro-pyrimidin-5-yl)-benzamide; Biphenyl-3,4′-dicarboxylic acid 4′-{[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-amide} 3-[(2-methoxy-ethyl)-amide]; Biphenyl-3,4′-dicarboxylic acid 4′-{[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-amide} 3-[(2-morpholin-4-yl-ethyl)-amide]; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(4-methylpiperazin-1-yl)pyrimidin-4-yl]benzamide; 4-[(4-{4-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethylcarbamoyl]phenyl}pyrimidin-2-yl)methylamino]butyric acid; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(2,2,2-trifluoroethoxy)pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(2-pyrrolidin-1-ylpyrimidin-4-yl)benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(2-hydroxymethylpyrrolidin-1-yl)-pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-y1)-ethyl]-4-[2-(carbamoylmethyl-N-methylamino)-pyrimidin-4-yl]benzamnide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(6-pyrrolidin-1-yl-hexylamino)pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(6-piperidin-1-ylhexylamino)pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(4-piperidin-1-ylbutylamino)pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(4-diethylaminobutylamino)pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(6-morpholin-4-ylhexylamino)pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl-4-[2-(6-dimethylaminohexylamino)pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(4-dimethylaminobutylamino)pyrimidin-4-yl]benzamide; 4-[2-(Bicyclo[2;2;1]hept-2-ylamino)pyrimidin-4-yl]-N-[2-(3-carbamimidoyl-1H-indol-5-yl)ethyl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-{2-[(2-hydroxy-ethyl)-N-methylamino]pyrimidin-4-yl}benzamide; N-[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(2-morpholin-4-yl-pyrimidin-4-yl)-benzamide; N-[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(cyclopropylmethyl-amino)-pyrimidin-4-yl]-benzamide; N-[2-(carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-[(2-methoxy-ethyl)-methyl-amino]-pyrimidin-4-yl]-benzamide; N-[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(3-hydroxy-propylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-carbamimidoyl-1H-indol-5-y)-ethyl]-4-[(2-hydroxy-ethyl)-propyl-amino]-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indole-5yl)-ethyl]-4-(2-piperidin-1-yl-pyrimidin-4-yl)benzamide; N-[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(ethyl-methyl-amino)-pyrimidin-4-yl]-benzamide; N-[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(4-hydroxy-piperidin-1-yl)-pyrimidin-4-yl]-benzamide; N-[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(2,3-dihydroxy-propylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-carbamimidoyl-1H-indol-1-y)-ethyl]-4-[2-[(2,3-dihydroxy-propyl)-methyl-amino]-pyrimidin-4-yl]-benzamide; N-[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-((s)-2-methoxymethyl-pyrrolidin-1-yl)-pyrimidin-4-yl]-benzamide; N-[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(2-piperazin-1-yl-pyrimidin-4-yl)-benzamide; N-[2-(3-carbamimidoyl-1H-indol-5-yl)-4-[2-[2-(2-oxo-imidazolidin-1-yl)-ethylamino]-pyrimidin-4-yl]-benzamide; N-[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(3-methoxy-propylamino)-pyrimidin-4-yl]-benzamide; 4-[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(2-hydroxy-ethylamino)-pyrimidin-4-yl]-benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)-ethyl]-4-[2-(2-methoxyethoxy)-pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(1-carbamoylethoxy)pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(6-dimethylaminohexyloxy)pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(2-pyrrolidin-1-yl-ethoxy)pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[2-(2-dimethylaminoethoxy)pyrimidin-4-yl]benzamide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-(1-oxypyridin-2-yl)benzamide; 2-Dimethylaminoethoxy)biphenyl-4-carboxylic acid [2-(3-carbamimidoyl-1H-indol-5-yl)ethyl]amide; 2′-(3-Dimethylaminopropoxy)biphenyl-4-carboxylic acid [2-(3-carbamimidoyl-1H-indol-5-yl)ethyl]amide; N-[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-4-(1-oxo-pyridin-3-yl)-benzamide; 4-[2-(acetylamino-methyl)-pyridin-4-yl]-N-[2-(3-carbamimidoyl-1H-indol-5-yl)-ethyl]-benzamide; Piperidine-4-carboxylic acid (4-[4-[2-(3-carbamimidoyl-1H-indol-5-yl)-ethylcarbamoyl]-phenyl-]-pyridin-2-ylmethyl)-amide; N-[2-(3-Carbamimidoyl-1H-indol-5-yl)ethyl]-4-[1-(3-dimethylaminopropyl)-6-oxo-1,6-dihydropyridin-3-yl]benzamide; 4-(2-Amino-1,1-dimethylethyl)-N-(2-[3-carbamimidoylindol-5-yl]ethyl)benzamide; and N-(2-[3-Carbamimidoylindol-5-yl]ethyl)-4-pyrid-4-ylbenzamide.
- 29. A pharmaceutical composition comprising a pharmaceutically effective amount of a compound according to claim 1 and a pharmaceutically acceptable carrier.
- 30. A method for treating a patient suffering from a physiological condition capable of being modulated by inhibiting activity of Factor Xa comprising administering to said patient a pharmaceutically effective amount of a compound according to claim 1.
- 31. The method according to claim 30 wherein the physiological condition is abnormal thrombus formation, acute myocardial infarction, unstable angina, thromboembolism, acute vessel closure associated with thrombolytic therapy, percutaneous transluminal coronary angioplasty, transient ischemic attacks, stroke, intermittent claudication or bypass grafting of the coronary or peripheral arteries, vessel luminal narrowing, restenosis post coronary or venous angioplasty, maintenance of vascular access patency in long-term hemodialysis patients, pathologic thrombus formation occurring in the veins of the lower extremities following abdominal, knee or hip surgery, a risk of pulmonary thromboembolism, or of disseminated systemic intravascular coagulopathy occurring in vascular systems during septic shock 32.
- 32. The method according to claim 30 wherein the physiological condition is abnormal thrombus formation, acute myocardial infarction, unstable angina, thromboembolism, acute vessel closure associated with thrombolytic therapy, transient ischemic attacks, intermittent claudication or bypass grafting of the coronary or peripheral arteries, restenosis post coronary or venous angioplasty, pathologic thrombus formation occurring in the veins of the lower extremities following abdominal, knee or hip surgery or a risk of pulmonary thromboembolism.
- 33. The method according to claim 30 wherein the physiological condition is stroke, vessel luminal narrowing, maintenance of vascular access patency in long-term hemodialysis patients, or disseminated systemic intravascular coagulopathy occurring in vascular systems during septic shock, or cancer.
- 34. A method of inhibiting Factor Xa comprising contacting a Factor Xa inhibitory amount of a compound according to claim 1 with a composition containing Factor Xa.
- 35. A method of inhibiting the formation of thrombin comprising contacting a Factor Xa inhibitory amount of a compound according to claim 1 with a composition containing Factor Xa.
Parent Case Info
This is a continuation of International Patent Application No. PCT/US99/30623. filed Dec. 22, 1999, which is, in turn, a continuation of U.S. patent application Ser. No. 60/113,710, filed Dec. 24. 1998, now abandoned.
Foreign Referenced Citations (7)
Number |
Date |
Country |
328200 |
Aug 1989 |
EP |
0 568 289 |
Nov 1993 |
EP |
0 328 200 |
Dec 1993 |
EP |
2 400 518 |
Mar 1979 |
FR |
2400518 |
Mar 1979 |
FR |
WO 9724118 |
Jul 1997 |
WO |
WO 9801428 |
Jan 1998 |
WO |
Non-Patent Literature Citations (3)
Entry |
Merriam Wedster's Collegiate Dictonary, 10th Edn., 1996, pp. 165 and 1320.* |
Lape et al., “An Invest. of the Anthyperensive properties . . . ”,Arch.Intl. Pharmacodyn, 171/2,394-414(1968).* |
Lape H.E. et al., An Investigation Of The Antihypertensive Properties Of A Series Of Indole And Azaindole Amidoximes with Particular Reference To 7-Azaindoxime and Indole-1-Acetamidoxime, Arch. int. Pharmacodyn., 1968, 171, No. 2. 394-414. |
Provisional Applications (1)
|
Number |
Date |
Country |
|
60/113710 |
Dec 1998 |
US |
Continuations (1)
|
Number |
Date |
Country |
Parent |
PCT/US99/30623 |
Dec 1999 |
US |
Child |
09/609103 |
|
US |